Table 1.
Correlation analysis of clinicopathological features between XBP1 and NSCLC patients.
| Characteristics | Number | XBP1 expression | P value | |
|---|---|---|---|---|
| High(n) | Low(n) | |||
| Age(years) | ||||
| <60 | 55 | 39 | 16 | 0.21 |
| ≥60 | 49 | 29 | 20 | |
| Gender | ||||
| Male | 78 | 53 | 25 | 0.341 |
| Female | 26 | 15 | 11 | |
| Smoking history | ||||
| No | 37 | 24 | 13 | 0.934 |
| Yes | 67 | 44 | 23 | |
| Pathological type | ||||
| Adenocarcinoma | 67 | 32 | 35 | 0.479 |
| Squamous cell carcinoma | 37 | 15 | 22 | |
| Differentiation | ||||
| Well | 24 | 18 | 6 | 0.007 |
| Moderate | 56 | 40 | 16 | |
| Poor | 24 | 9 | 15 | |
| Tumor invasion | ||||
| T1 | 31 | 20 | 11 | 0.989 |
| T2 | 44 | 29 | 15 | |
| T3 | 21 | 13 | 8 | |
| T4 | 8 | 5 | 3 | |
| Lymph node metastasis | ||||
| Yes | 39 | 30 | 9 | 0.009 |
| No | 65 | 36 | 29 | |
| TNM stage | ||||
| I | 33 | 17 | 16 | 0.034 |
| II | 35 | 21 | 14 | |
| III+IV | 36 | 29 | 7 | |